[1] 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018更新版). 实用肝脏病杂志, 2018, 21:177-186.
[2] Wong VW, Chan WK, Chitturi S, et al. The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment. J Gastroenterol Hepatol,2018,33:70-85.
[3] Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology,2018,67:328-357.
[4] Siddiqui MS, Harrison SA, Abdelmalek MF, et al. Case defifinitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science. Hepatology,2018,67:2001-2012.
[5] Chang Y, Cho YK, Kim Y, et al. Nonheavy drinking and worsening of noninvasive fifibrosis markers in nonalcoholic fatty liver disease: a cohort study. Hepatology,2019,69:64-75.
[6] Younossi ZM, Stepanova M, Ong J, et al. Effects of alcohol consumption and metabolic syndrome on mortality in patients with nonalcoholic and alcohol-related fatty liver disease. Clin Gastroenterol Hepatol,2019,17:1625-1633.
[7] Eslam M, Sanyal AJ, George J. Toward more accurate nomenclature for fatty liver disease. Gastroenterology,2019,157:590-593. |
